Register for this CME-certified symposium

Clinical Controversies in the Treatment of Anemia:
Appropriate Use of ESAs in a Time of Change

Hyatt Regency Chicago
Crystal Ballroom
West Tower, Green (Ground) Level
Chicago, Illinois


Thank you for your interest in this live program. Registration is closed, as the current schedule has been completed. Please email info@clinicaloptions.com for more information.

This symposium will discuss the clinical impact of anemia on patients with cancer and the current treatment options for anemia, including erythropoiesis-stimulating agents (ESAs). Current guidelines and recommendations for ESA use in patients with cancer also will be discussed.

Not an official event of the ASCO Annual Meeting. Not sponsored or endorsed by ASCO or The ASCO Foundation.

Program Overview

You are invited to attend a novel CME-certified symposium including several comprehensive didactic presentations and a unique, interactive case-based session. Topics addressed include:

  • Biology of Anemia and Impact on the Patient
  • Anemia Treatment: Understanding the Risks to Achieve Patient Benefit
  • Treatment of Anemia in 2008 and Beyond: Applying the Latest Guidelines to Patient Cases
  • The Future of ESA Therapy

Purpose

The purpose of this activity is to provide clinicians with an experiential environment that engages participants in learning the latest guidelines, regulatory recommendations, and practical application of erythropoiesis-stimulating agents (ESAs) for the appropriate management of anemia in patients with cancer.

Target Audience

This activity is intended for physicians, registered nurses, and other healthcare providers interested in learning about the latest clinical and regulatory updates for appropriate management of anemia in oncology patients and the appropriate use of erythropoiesis-stimulating agents (ESAs) in clinical practice.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the biology of anemia and its clinical impact on cancer patients
  • Discuss efficacy and safety data related to appropriate use of ESAs in patients with cancer
  • Explain the possible risks and benefits of ESAs in the management of anemia in the oncology setting
  • Discuss recent updates from regulatory agencies and changes to practice guidelines regarding the clinical utility of ESAs
/upload/oncology/registration/asco_anemia_imageforregpage.gif
/upload/global/providers/pim_110.gifJointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.


Supported by an educational donation from

There are no fees required to participate in this educational activity.